© 2004 BMJ Publishing Group Ltd
BJO at a glance
| The first 150 words of the full text of this article appear below. |
Considerable controversy surrounds the question of whether or not photodynamic therapy (PDT) for age related macular degeneration is cost effective. Smith and coworkers used data from a variety of sources in the United Kingdom to try to evaluate the cost effectiveness of this therapy. They conclude that early treatment with PDT leads to increased efficiency. When considering only the cost of therapy treating patients with lower levels of visual acuity is not considered to be cost effective. However, they do suggest a broad perspective, which incorporates NHS treatment costs and social care costs over a long period of time, may show that PDT yields reasonable value for money.
See p 1107
Cataracts occur in up to 50% of patients with uveitis. It is generally considered that ocular information should be minimised for at least 2 months before surgery. Meacock and coworkers in a randomised prospective study have demonstrated that a
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Relevant Articles
- Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case
- D H Smith, P Fenn, and M Drummond
Br. J. Ophthalmol. 2004 88: 1107-1112.[Abstract] [Full Text] [PDF]
- Steroid prophylaxis in eyes with uveitis undergoing phacoemulsification
- W R Meacock, D J Spalton, L Bender, R Antcliff, C Heatley, M R Stanford, and E M Graham
Br. J. Ophthalmol. 2004 88: 1122-1124.[Abstract] [Full Text] [PDF]
- Optic neuritis: chemokine receptor CXCR3 and its ligands
- T L Sørensen, H Roed, and F Sellebjerg
Br. J. Ophthalmol. 2004 88: 1146-1148.[Abstract] [Full Text] [PDF]
- Subthreshold micropulse diode laser treatment in diabetic macular oedema
- M L Laursen, F Moeller, B Sander, and A K Sjoelie
Br. J. Ophthalmol. 2004 88: 1173-1179.[Abstract] [Full Text] [PDF]
- An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy
- J A Cardillo, M E Farah, J Mitre, P H Morales, R A Costa, L A S Melo, B Kuppermann, R Jorge, and P Ashton
Br. J. Ophthalmol. 2004 88: 1201-1205.[Abstract] [Full Text] [PDF]
- Partial resolution of diabetic macular oedema after systemic treatment with furosemide
- A P Ciardella
Br. J. Ophthalmol. 2004 88: 1224-1225.[Extract] [Full Text] [PDF]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
